drugset / Trial / NCT07412665
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Phase 0
Not yet recruiting
10 enrolled
Beijing Geekgene Technology Co., LTD
Peking University Cancer Hospital & Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is an open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.
Timeline
- Start
- 2026-06
- Primary completion
- 2027-03-31
- Completion
- 2028-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GK01 | Cell therapy | — | — |